VIM and prostate cancer: To demonstrate the utility of PACS-based TaqMan RT-PCR to identify specific cells in a heterogeneous population, we targeted expression of vimentin in DU145 prostate cancer cells spiked into Raji B-lymphocyte-derived cells.